Press Releases


Lilly Confirms Date and Conference Call for First-Quarter 2020 Financial Results Announcement

April 8, 2020

Tags |  Financial

INDIANAPOLIS , April 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2020 financial results on Thursday, April 23, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial




Eli Lilly and Company to Hold 2020 Annual Meeting of Shareholders Virtually

April 7, 2020

Tags |  Financial

INDIANAPOLIS , April 7, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that due to the public health impact of the coronavirus outbreak, and to support the health and well-being of its employees, shareholders, and other meeting participants, the Board of Directors of Eli




Lilly to Participate in Barclays Global Healthcare Conference

March 9, 2020

Tags |  Financial

INDIANAPOLIS , March 9, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on Tuesday, March 10, 2020 . Ilya Yuffa , vice president, U.S. Diabetes, and Jeffrey Emmick , M.D., Ph.D., vice president, diabetes product development, will




Lilly to Participate in Cowen Health Care Conference

February 21, 2020

Tags |  Financial

INDIANAPOLIS , Feb. 21, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a fireside chat




Lilly To Participate in SVB Leerink Global Healthcare Conference

February 21, 2020

Tags |  Financial

INDIANAPOLIS , Feb. 21, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020 . Patrik Jonsson , Lilly senior vice president and president of Lilly Bio-Medicines, will participate in a




Lilly to Participate in Guggenheim Healthcare Talks Idea Forum

February 7, 2020

Tags |  Financial

INDIANAPOLIS , Feb. 7, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks Idea Forum on Thursday, February 13, 2020 . Jacob Van Naarden , chief operating officer for Loxo Oncology at Lilly; Eric Dozier , vice president, Lilly Oncology North




Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition

January 30, 2020

Tags |  Financial

- Revenue in the fourth quarter of 2019 grew 8 percent, driven by 10 percent volume growth. Key growth products launched since 2014, including Trulicity, Taltz, Jardiance, Verzenio, Olumiant, Emgality, Basaglar, and Cyramza, contributed 14 percentage points of revenue growth and represented




Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement

January 16, 2020

Tags |  Financial

INDIANAPOLIS , Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the




Lilly to Participate in J.P. Morgan Healthcare Conference

January 2, 2020

Tags |  Financial

INDIANAPOLIS , Jan. 2, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 . David A. Ricks , Lilly's chairman and chief executive officer, will participate in a fireside chat at 5:30 p.m.




Lilly Announces 2020 Financial Guidance, Updates 2019 Guidance

December 17, 2019

Tags |  Financial

- Lilly expects 2020 to be a strong year of financial and operational performance, characterized by robust top-line growth, margin expansion, continued pipeline progress and solid cash flow. - 2020 revenue is expected to be between $23.6 billion and $24.1 billion, driven by volume growth from key